The effect of poly(lactic-co-glycolic acid) (PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds

Bio-Medical Materials and Engineering

Volumn 22, Issue 5, 2012, Pages 289-300

  Zhao, Lang ^a   Wu, Chengtie ^a   Lin, Kaili ^a   Chang, Jiang ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

CaSiO3 scaffolds; compressive strength; drug release; PLGA

Indexed keywords

BIOACTIVE PROPERTIES; BIOLOGICAL SOLUTIONS; BONE TISSUE ENGINEERING; BURST RELEASE; DRUG RELEASE; HIGH POROSITY; INTERCONNECTED POROUS STRUCTURE; INTRINSIC VISCOSITY; IONIC PRODUCTS; LARGE PORE SIZE; PH VALUE; PLGA; POLY(LACTIC-CO-GLYCOLIC ACID); SUSTAINED RELEASE;

BIOACTIVITY; BIODEGRADATION; BONE; CALCIUM SILICATE; COATINGS; COMPRESSIVE STRENGTH; COPOLYMERS; DRUG PRODUCTS; IONIC STRENGTH; MECHANICAL PROPERTIES; PHOSPHATE MINERALS; SCAFFOLDS; SINTERING;

SCAFFOLDS (BIOLOGY);

APATITE; CALCIUM DERIVATIVE; CALCIUM SILICATE; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SILICATE; TISSUE SCAFFOLD;

ARTICLE; BONE; CHEMISTRY; COMPRESSIVE STRENGTH; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; METHODOLOGY; PH; POROSITY; SURFACE PROPERTY; TISSUE ENGINEERING;

APATITES; BONE AND BONES; CALCIUM COMPOUNDS; COMPRESSIVE STRENGTH; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; POLYGLYCOLIC ACID; POROSITY; SILICATES; SURFACE PROPERTIES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84867559188     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-2012-0719     Document Type: Article

References (35)

1. R. Langer and J.P. Vacanti, Tissue engineering, Science 260 (1993), 920-926
2. K.L. Lin, J. Chang and Z. Wang, Fabrication and the characterization of the bioactivity and degradability of macroporous calcium silicate bioceramics in vitro, J. Inorg. Mater. 20 (2005), 692-698
3. S.Y. Ni, J. Chang and L. Chou, A novel bioactive porous CaSiO3 scaffold for bone tissue engineering, J. Biomed. Mater. Res. A 76 (2006), 196-205
4. S.Y. Ni, J. Chang, L. Chou and W.Y. Zhai, Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro, J. Biomed. Mater. Res. B 80 (2007), 174-183
5. S.F. Xu, K.L. Lin, Y.Y. Hu, Z. Wang, J. Chang, L. Wang, J.X. Lu and C.Q. Ning, Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics, Biomaterials 29 (2008), 2588-2596
6. A. El-Ghannam, P. Ducheyne and I.M. Shapiro, Formation of surface reaction products on bioactive glass and their effects on the expression of the osteoblastic phenotype and the deposition of mineralized extracellular matrix, Biomaterials 18 (1997), 295-303
7. I.A. Silver, J. Deas and M. Erecinska, Interactions of bioactive glasses with osteoblasts in vitro: effects of 45S5 bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability, Biomaterials 22 (2001), 175-185
8. H. Li and J. Chang, Preparation and characterization of bioactive and biodegradable wollastonite/poly(D,L-lactic acid) composite scaffolds, J. Mater. Sci. Mater. Med. 15 (2004), 1089-1095
9. H. Li and J. Chang, Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds, Biomaterials 25 (2004), 5473-5480
10. X. Li and J. Chang, Preparation, characterization of bioactive collagen/wollastonite composite scaffolds, J. Mater. Sci. Mater. Med. 16 (2005), 361-365
11. J.Wei, S.J. Heo, D.H. Kim, S.E. Kim, Y.T. Hyun and J.W. Shin, Comparison of physical, chemical and cellular responses to nano-and micro-sized calcium silicate/poly(epsilon-caprolactone) bioactive composites, J. R. Soc. Interface 5 (2008), 617-630
12. N.A. Peppas, Y. Huang, M. Torres-Lugo, J.H. Ward and J. Zhang, Physicochemical foundations and structural design of hydrogels in medicine and biology, Ann. Rev. Biomed. Eng. 2 (2000), 9-27
13. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang and R. Langer, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8 (1991), 713-720
14. L.E. Freed, V.N. Gordana and R. Langer, Biodegradable polymer scaffolds for tissue engineering, Biotechnology 12 (1994), 689-693
15. K.A. Athanasiou, G.G. Niederauer and C.M. Agrawal, Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid copolymers, Biomaterials 17 (1996), 93-102
16. M. Vert, S.M. Li, G. Speniehauer and P. Guerir, Bioresorbability and biocompatibility of aliphatic polyesters, J. Mater. Sci. Mater. Med. 3 (1992), 432-446
17. Q. Cai, J.Z. Bei and S.G. Wang, Study on the biocompatibility and degradation behaviour of poly(l-lactide-co-glycolide) in vitro and in vivo, Chin. J. Funct. Polym. 13 (2000), 249-254
18. K. Rezwan, Q.Z. Chen, J.J. Blaker and A.R. Boccaccini, Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering, Biomaterials 27 (2006), 3413-3431
19. M. Therina, P. Christela, S. Li, H. Garreau and M. Vert, In vivo degradation of massive poly(?-hydroxy acids): validation of in vitro findings, Biomaterials 13 (1992), 594-600
20. V. Mouriño and A.R. Boccaccini, Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds, J. R. Soc. Interface 7 (2010), 209-227
21. W.J.E.M. Habraken, J.G.C. Wolke and J.A. Jansen, Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering, Adv. Drug Deliv. Rev. 59 (2007), 234-248
22. L.Z. Zhao, X.X. Yan, X.F. Zhou, L. Zhou, H.N.Wang, H.W. Tang et al., Mesoporous bioactive glasses for controlled drug release, Micropor. Mesopor. Mat. 109 (2008), 210-215
23. T. Kokubo and H. Takadama, How useful is SBF in predicting in vivo bone bioactivity?, Biomaterials 27 (2006), 2907-2915
24. O. Barou, S. Mekraldi, L. Vico, G. Boivin, C. Alexandre and M.H. Lafage-Proust, Relationships between trabecular bone remodeling and bone vascularization: a quantitative study, Bone 30 (2002), 604
25. H. Li and J. Chang, Preparation and characterization of bioactive and biodegradable wollastonite/poly(D,L-lactic acid) composite scaffolds, J. Mater. Sci. Mater. Med. 15 (2004), 1089-1095
26. X. Li and J. Chang, Preparation and characterization of bioactive collagen/wollastonite composite scaffolds, J. Mater. Sci. Mater. Med. 16 (2005), 361-365
27. T. Kokubo, H. Kim and M. Kawashita, Novel bioactive materials with different mechanical properties, Biomaterials 24 (2003), 2161-2175
28. A.G. Hausberger and P.P. Deluca, Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres, J. Pharm. Biomed. Anal. 13 (1995), 747-760
29. S.C.J. Loo, C.P. Ooi and Y.C.F. Boey, Influence of electron-beam radiation on the hydrolytic degradation behaviour of poly(lactide-co-glycolide) (PLGA), Biomaterials 26 (2005), 3809-3817
30. L. Zhao, K. Lin, M. Zhang, C. Xiong, Y. Bao, X. Pang and J. Chang, The influences of poly(lactic-co-glycolic acid) (PLGA) coating on the biodegradability, bioactivity and biocompatibility of calcium silicate bioceramics, J. Mater. Sci. 46 (2011), 4986-4993
31. H. Li and J. Chang, In vitro degradation of porous degradable and bioactive PHBV/wollastonite composite scaffolds, Polym. Degrad. Stabil. 87 (2005), 301-307
32. Y.F. Chou, W. Huang, J.C. Dunn, T.A. Miller and B.M. Wu, The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression, Biomaterials 26 (2005), 285-295
33. C. Wu, J. Chang, W. Zhai and S. Ni, A novel bioactive porous bredigite (Ca(7)MgSi(4)O(16)) scaffold with biomimetic apatite layer for bone tissue engineering, J. Mater. Sci. Mater. Med. 18 (2007), 857-864
34. Y. Zhu, Y. Zhang, C. Wu, Y. Fang, J. Wang and S. Wang, The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds, Micropor. Mesopor. Mater. 143 (2011), 311-319
35. M. Hartmann, Ordered mesoporous materials for bioadsorption and biocatalysis, Chem. Mater. 17 (2005), 4577-4593